Skip to main content
Figure 2 | BMC Pulmonary Medicine

Figure 2

From: Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study

Figure 2

CC16 and sRAGE levels in VAP patients and control patients. Plasma levels of Clara cell protein (CC16) and soluble receptor for advanced glycation end products (sRAGE) in patients who developed ventilator-associated pneumonia (left graphs) and mechanically ventilated control patients (right graphs). In the left graphs day 0 represents the day of ventilator-associated pneumonia diagnosis. In the right graphs day 0 represents the day of start of mechanical ventilation.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us